A Pilot Study of Tumor-Specific Peptide Vaccination and IL-2 With or Without Autologous T Cell Transplantation in Recurrent Pediatric Sarcomas
Clinical trial NCT00001564 · COMPLETED
Trial details
- NCT number
- NCT00001564
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1996-12-23
- Primary completion
- 2007-10-25
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.